Form 4: Madrigal Director Exercises Stock Options

Madrigal Pharmaceuticals Director Richard S. Levy exercised 2,500 stock options at $7.36 per share, increasing his direct common stock holdings.

Summary

• Richard S. Levy, a Director of Madrigal Pharmaceuticals, Inc. (MDGL), exercised 2,500 stock options.
• The exercise price for these options was $7.36 per share.
• Following this transaction, Mr. Levy directly owns 27,697 shares of Madrigal Pharmaceuticals Common Stock.
• The transaction was executed on February 23, 2026, and was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
• The exercised options were fully vested and exercisable, with an expiration date of August 11, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, as a director increasing their direct equity stake, even through option exercise, generally indicates continued alignment with shareholder interests and confidence in the company's value.

Positives

• The exercise of options by a director indicates continued confidence in the company's long-term prospects, as it increases their direct equity stake.
• The transaction was conducted under a Rule 10b5-1(c) plan, suggesting a pre-planned and systematic approach to managing equity holdings rather than a reaction to immediate market conditions.

Negatives

• The filing does not disclose the market price of MDGL common stock on the transaction date, making it difficult to assess the immediate financial gain for the director or the implied valuation.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider option exercises are common in the biotechnology and pharmaceutical sectors, often reflecting a component of executive compensation and a mechanism for insiders to realize value from long-term incentive plans. This specific transaction does not provide broader industry insights beyond standard compensation practices.

Related Party Transactions

• Richard S. Levy, a Director of Madrigal Pharmaceuticals, Inc., exercised stock options granted by the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The transaction increases the director's direct ownership, potentially aligning his interests more closely with other shareholders.

Key Dates

Recommendation

This Form 4 filing details a routine insider option exercise under a pre-planned trading arrangement. While it shows a director increasing their direct equity stake, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

Madrigal Pharmaceuticals, MDGL, Richard S. Levy, Director, Stock Option Exercise, Insider Transaction, Form 4, Equity Holdings, Rule 10b5-1